Thomson Scientific is pleased to provide you with information on products and services that are related to your research. If you can not view this e-mail properly, click here.



Welcome to the May edition of the Thomson Pharma® e-bulletin. As a registered
user of Thomson Pharma, you are entitled to receive exclusive news of our latest releases, free expert reports you can download, and advice on how to get the most out of your Thomson data solution.

We'll also show you how our commitment to your information needs powers constant development of Thomson Pharma, with more drugs, more company reports and more literature and news added every month.

In this bulletin:

Forthcoming exhibitions and events

Thomson Bio/Pharma Forum

Thomson Bio/Pharma Forum is a forum which allows professionals to share their views on the news, trends and ideas shaping the biotech and pharmaceutical industries.

Click here to have your say on the forum.

In the spotlight

The Ones To Watch – latest edition out now

Every quarter, Thomson Scientific takes the pulse of the industry with The Ones To Watch, our lively free review of the most exciting phase changes in the pharmaceutical pipeline.

The latest edition, covering the period January to March 2007, is out now.

Don’t miss out — visit The Ones to Watch subscription page. Here you can subscribe to receive this and future editions, delivered direct to your desktop every quarter. There is no charge and subscription is without obligation.To view an example back issue, click here


Who is Making the Biggest Splash – download now

Our free quarterly review Who is Making the Biggest Splash? ranks the leading companies, research agencies and non-commercial bodies to give an expert insight into the shape of the industry. Subscribers can now download the third edition, covering the period December 2006 to February 2007.

Click here to subscribe
to Who is Making the Biggest Splash?


Drug of the month —pimavanserin tartrate

Each month, Thomson Pharma spotlights a drug of special interest and writes an exclusive overview.

This month's drug is pimavanserin tartrate, the drug is currently in phase II trials for schizophrenia, insomnia and PD-related psychomotor disorder and psychosis.
Click here to read about this month's drug

Thomson Pharma statistics

  • Number of new drugs added in the last month:136
  • Number of drug records updated:1908
  • Number of drugs changing phase of development:
  • Number of new companies added in the last month:32

  • Meeting reports published: 47 from 35 individual conferences

Meetings highlights include:

American Association for Cancer Research 98th Annual Meeting (Part V) - OVERNIGHT REPORT, Los Angeles, CA, USA, 14-18 April 2007

HIV Vaccines: From Basic Research to Clinical Trials – Keystone Symposia, Whistler, Canada, 25-30 March, 2007


ALLICENSE 2007 - A Recombinant Capital Conference, Enhancing Productivity Through Alliance, San Francisco, CA, USA, 11-12 April 2007

BioTrinity 2007, Highlights from the Emerging Company Showcase, Oxford, UK, 27-28 March 2007

Thomson Pharma did you know?

Did you know that when exporting to Word you can export the whole report or your own selection of fields?

Did you know you can link to a drug evaluation sheet containing additional information by clicking on one of the hyperlinks in the DRUGDEX overview portlet in the drug report? This evaluation sheet contains more pharmacokinetic information, black box warnings and information on dosing, cautions and clinical applications

Did you know that you could shape the development of Thomson Pharma by clicking on the feedback button which is situated at the top of the screen in the dark blue tool bar? Thomson Pharma has it’s own Customer Values Manager whose role is to collect customer feedback and relay this to Product Development.

Online training demonstrations and discussions

Click here to link to the new Thomson Pharma online training demonstrations.




Copyright © 2007 The Thomson Corporation

Thomson Scientific
3501 Market Street, Philadelphia, PA 19104 USA
14 Great Queen Street, London WC2B 5DF UK
Placeside Bldg. 5F, 1-1-1 Hitotsubashi, Chiyoda-ku, Tokyo 100-0003 Japan

This communication was sent to you in the sincere belief that you would find its message useful. We would like to continue to use your contact details to provide you, by email, telephone or post, with information about Thomson Scientific products and events.

For information about our privacy policies or to change your communication preferences, please
go to
www.scientific.thomson.com/preference.
P7009-4.

 
Thomson Pharma e-bulletin - March 2007

Thomson Scientific is pleased to provide you with information on products and services that are related to your research. If you can not view this e-mail properly, click here.



Welcome to the May edition of the Thomson Pharma® e-bulletin. As a registered
user of Thomson Pharma, you are entitled to receive exclusive news of our latest releases, free expert reports you can download, and advice on how to get the most out of your Thomson data solution.

We'll also show you how our commitment to your information needs powers constant development of Thomson Pharma, with more drugs, more company reports and more literature and news added every month.

In this bulletin:

Forthcoming exhibitions and events

Thomson Pharma 7.1 release update

The latest upgrade to Thomson Pharma has added improvements in the following areas:

  • matching more closely the functionality of our legacy products
  • extending our expert analysis and value-add content
  • enlarging the home pages, portlets and alerting functions
  • adding new and more powerful search and browse tools
  • adding a number of new reports features
  • increasing export and print facilities

For a full update of these enhancements click here

In the spotlight

The Ones To Watch – latest edition out now

Every quarter, Thomson Scientific takes the pulse of the industry with The Ones To Watch, our lively free review of the most exciting phase changes in the pharmaceutical pipeline.

The latest edition, covering the period January to March 2007, is out now.

Don’t miss out — visit The Ones to Watch subscription page. Here you can subscribe to receive this and future editions, delivered direct to your desktop every quarter. There is no charge and subscription is without obligation.To view an example back issue, click here


Who is Making the Biggest Splash – download now

Our free quarterly review Who is Making the Biggest Splash? ranks the leading companies, research agencies and non-commercial bodies to give an expert insight into the shape of the industry. Subscribers can now download the third edition, covering the period December 2006 to February 2007.

Click here to subscribe
to Who is Making the Biggest Splash?


Drug of the month —pimavanserin tartrate

Each month, Thomson Pharma spotlights a drug of special interest and writes an exclusive overview.

This month's drug is pimavanserin tartrate, the drug is currently in phase II trials for schizophrenia, insomnia and PD-related psychomotor disorder and psychosis.
Click here to read about this month's drug

Thomson Pharma statistics

  • Number of new drugs added in the last month:136
  • Number of drug records updated:1908
  • Number of drugs changing phase of development:
  • Number of new companies added in the last month:32

  • Meeting reports published: 47 from 35 individual conferences

Meetings highlights include:

American Association for Cancer Research 98th Annual Meeting (Part V) - OVERNIGHT REPORT, Los Angeles, CA, USA, 14-18 April 2007

HIV Vaccines: From Basic Research to Clinical Trials – Keystone Symposia, Whistler, Canada, 25-30 March, 2007


ALLICENSE 2007 - A Recombinant Capital Conference, Enhancing Productivity Through Alliance, San Francisco, CA, USA, 11-12 April 2007

Life Sciences Alliance World 2007 - A Terrapinn Conference (Part I), London, UK, Searle B, IDdb Meeting Report, April 16-18 2007


BioTrinity 2007, Highlights from the Emerging Company Showcase, Oxford, UK, 27-28 March 2007

Thomson Pharma did you know?

Did you know that when exporting to Word you can export the whole report or your own selection of fields?

Did you know you can link to a drug evaluation sheet containing additional information by clicking on one of the hyperlinks in the DRUGDEX overview portlet in the drug report? This evaluation sheet contains more pharmacokinetic information, black box warnings and information on dosing, cautions and clinical applications

Did you know that you could shape the development of Thomson Pharma by clicking on the feedback button which is situated at the top of the screen in the dark blue tool bar? Thomson Pharma has it’s own Customer Values Manager whose role is to collect customer feedback and relay this to Product Development.

Online training demonstrations and discussions

Click here to link to the new Thomson Pharma online training demonstrations.

Thomson Bio/Pharma Forum is a forum which allows professionals to share their views on the news, trends and ideas shaping the biotech and pharmaceutical industries. Click here to have your say.




Copyright © 2007 The Thomson Corporation

Thomson Scientific
3501 Market Street, Philadelphia, PA 19104 USA
14 Great Queen Street, London WC2B 5DF UK
Placeside Bldg. 5F, 1-1-1 Hitotsubashi, Chiyoda-ku, Tokyo 100-0003 Japan

This communication was sent to you in the sincere belief that you would find its message useful. We would like to continue to use your contact details to provide you, by email, telephone or post, with information about Thomson Scientific products and events.

For information about our privacy policies or to change your communication preferences, please
go to
www.scientific.thomson.com/preference.
P7009-4.